Arizona Liver Health

Come together with us at the Liver Life Walk on November 3, 2024, at Kiwanis Park in Tempe, AZ! Hosted by the American Liver Foundation (ALF), this uplifting event is a powerful opportunity to unite, celebrate, and raise vital awareness and funds for liver health. Don’t miss the chance to hear from our Chief Medical Officer at the Medical Hall of Heroes, where he’ll provide valuable insights into liver care and early detection.   📍 Location: North Soccer Field, Kiwanis Park, 5500 South Mill Ave. Tempe, AZ 85283 (Entry via W. Baseline Rd & S. Ash Avenue)   Let’s walk side by side to support the liver community! Support the cause by donating to the Arizona Liver Health – Liver Lovers team: Donate Here: https://lnkd.in/gqj7hxVY Parking Instructions: https://lnkd.in/gagMmVMn Anita Kohli Naim Alkhouri, MD, FAASLD Richard Manch Yessica Sachdeva Ann Moore Tessa Janovsky Angie Coste Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Fatty Liver Alliance Liver Life Walk

Fatty liver disease affects millions worldwide, often progressing without noticeable symptoms. Early detection is crucial, and non-invasive tools like FibroScan can help identify issues before complications arise. With Arizona Liver Health, we can offer your patients advanced diagnostic options and promote lifestyle changes that lead to better outcomes. We accept physician referrals to ensure timely care for your patients. Let’s collaborate to improve liver disease management together. We Accept Physician Referrals: https://lnkd.in/gmzASu_z Naim Alkhouri, MD, FAASLD, Anita Kohli Richard Manch Ann Moore Tessa Janovsky Rida Nadeem, MD, MSPH Angie Coste Esteban Rafael Lugo Morales Reichard R. Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Echosens Justin A. Reynolds, MD

Join our Chief Medical Officer, Dr. Naim Alkhouri, this Monday, October 28 at 12:30 PM MST, for the latest installment of Monster MASH Mondays on Medscape. Dr. Alkhouri, joined by Dr. Alina Allen from the Mayo Clinic, will dive into the critical role of noninvasive testing (NITs) in identifying patients for treatment and clinical trials, specifically in metabolic dysfunction-associated steatohepatitis (MASH). Gain insights from top experts on patient identification, treatment pathways, and the latest guidelines in MASH management. Don’t miss this final October session on all things MASH! Join the discussion to stay informed and engaged with the latest advancements. Link: https://lnkd.in/gHQFjMpx #ArizonaLiverHealth #MASH #Medscape #NIT #ClinicalTrials Medscape Arizona Liver Health Anita Kohli Richard Manch Ann Moore Tessa Janovsky Angie Coste Michelle Jones Kelly Nick Engelke Michelle Long Madrigal Pharmaceuticals Novo Nordisk Echosens CIMA Sciences, LLC Fibronostics Kevin Murrey Sonic Incytes Medical Corp.

At VEN Centers, our outreach teams know that identifying individuals with Hepatitis C is just the beginning. The true struggle is helping people complete treatment when they lack stable housing or even basic necessities. Through strong community partnerships with organizations like Andre House and Circle the City, we’ve been able to form lasting relationships that help us reconnect with individuals and provide consistent care. Together, we ensure that those who are resource-insufficient can still receive treatment and a cure for Hepatitis C, along with other vital support to help them find stability in life. Watch our video to learn more about how we’re overcoming these barriers and making a difference in the lives of those in need. To learn how to partner with us: https://lnkd.in/g-ebgXKq #VENCenters #HepatitisC #CommunityCare #HealthcareForAll #EndHepC #OutreachMatters #HealthEquity #CommunitySupport Anita Kohli Brennin Palfrey Dylan Moore Ann Moore Richard Manch Tessa Janovsky Angie Coste Kylee Newgass Rida Nadeem, MD, MSPH Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Andre House Circle the City

Introducing Zack DeFrancis, one of our expert Research APPs at Arizona Liver Health. Zack is here to share his insights on the importance of liver scans, like the FibroScan, from both a provider’s perspective and a patient’s experience. We welcome referrals from all medical fields, including Primary Care, Gastroenterology, Endocrinology, and Harm Reduction. By partnering with us, you can trust that your patients will receive the highest level of specialized liver care. We stay in close communication with referring providers, ensuring you’re always informed of our recommendations and your patients’ progress. Refer your patients today and discover why so many providers trust Arizona Liver Health for their liver care needs. Learn more about our referral process. https://lnkd.in/ggB5-gCj #LiverHealth #ProviderReferral #FibroScan #SpecializedCare #ArizonaLiverHealth Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Tessa Janovsky Rida Nadeem, MD, MSPH Angie Coste Esteban Rafael Lugo Morales Reichard R. Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Echosens Justin A. Reynolds, MD

Here in Hollywood!! Wrapping up a successful IDWeek24! Thank you to all the amazing speakers, Infectious Diseases Society of America professionals / clinicians and industry / sponsors who made this meeting a great opportunity to learn and network with so many amazing thought leaders! Dr. Kohli and I had great discussions and are looking forward to continuing our discussions with many network connections! If we didn’t get a chance to meet or if you couldn’t attend the meeting this week, please contact Michelle at mjones@azclinicaltrials.com or +1 303-406-1735. #ClinicalTrials #Phase1Trials #DiversePopulations #ACTImaging #ACTPhase1 Anita Kohli Michelle Jones Naim Alkhouri, MD, FAASLD Richard Manch Ann Moore Rida Nadeem, MD, MSPH Angie Coste Tessa Janovsky Nick Engelke Kelly Black Anne Payne Desirae Trotter

As healthcare professionals, we know that early detection is paramount in the fight against liver disease. Conditions like MASLD (formerly NAFLD), hepatitis, and liver cancer can progress silently, often showing no symptoms until it's too late for effective intervention. At Arizona Liver Health, we are committed to equipping providers with the best tools for early liver disease detection. Our clinics utilize advanced, non-invasive diagnostics to help identify liver damage at its earliest stages, giving patients the best chance at prevention and successful treatment. Why Promote Regular Liver Screenings? -Early diagnosis leads to significantly improved patient outcomes -Identifies silent conditions before irreversible damage occurs -Helps manage at-risk populations, including those with diabetes, excess weight, or other metabolic conditions Encouraging your patients to get regular liver screenings can save lives. Let’s work together to prioritize liver health and reduce the burden of liver disease in our communities. Submit a referral: https://lnkd.in/gmzASu_z Anita Kohli Naim Alkhouri, MD, FAASLD Richard Manch Yessica Sachdeva Ann MooreTessa Janovsky Angie Coste Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Fatty Liver Alliance American Association for the Study of Liver Diseases (AASLD) American Liver Foundation EASL | The Home of Hepatology Summit Clinical Research

It was an honor to partner with The Mexican Consulate, to offer free Hep C testing and Fibroscans to our community. Here's what Brennin Palfrey, VEN Centers Central AZ manager, had to say about this past weekends event: "The Mexican Consulate is a well organized entity that provides vital resources, documents, and emergency assistance to the members they are serving. Not only do they fulfil their role as a consulate, The Mexican Consulate offers resources and brings the community together through celebration. It was an honor to work along side them in providing vital resources to the community." - Brennin Palfrey #CommunityHealth #ProviderPartnership #CommunitySupport #HealthcareAccess Anita Kohli Brennin Palfrey Dylan Moore Ann Moore Richard Manch Tessa Janovsky Angie Coste Kylee Newgass Michelle Jones Kelly Black Nick Engelke Anne PayneDesirae Trotter

Dr. Anita Kohli, CEO & Director of Clinical Research, and Michelle Jones, Sr. VP Commercial Operations will be attending IDWeek 2024 in Los Angeles, CA on October 18-19! We would enjoy the opportunity to meet with you and discuss how Arizona Clinical Trials (ACT) could be a valued partner to your clinical trial research programs! Our ACT program offers an extensive Phase 1 and 2-4 trial capabilities, with a focus on diverse participant populations, adaptive recruitment and rapid trial initiation with cutting-edge facilities including in-house research imaging and advanced lab services. We’re looking forward to partnering with organizations interested in utilizing our clinical trial expertise. To schedule a meeting, please contact Michelle at mjones@azclinicaltrials.com or +1 303-406-1735. #ClinicalTrials #Phase1Trials #DiversePopulations #ACTImaging #ACTPhase1 Anita Kohli Michelle Jones Naim Alkhouri, MD, FAASLD Richard Manch Ann Moore Rida Nadeem, MD, MSPH Angie Coste Tessa Janovsky Esteban Rafael Lugo Morales Reichard R. Nick Engelke Kelly Black Anne Payne Desirae Trotter

Our very own Naim Alkhouri, MD, FAASLD chatted with Michael Betel from Fatty Liver Alliance on the topic of lifestyle management strategies for patients living with MASH, all part of the Monster MASH Monday series hosted by Medscape Education! American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, Global NASH Council, Global Liver Institute, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, The Forum for Collaborative Research: Jörn M. Schattenberg, Manal Abdelmalek, Supriya Joshi, Meena Bansal, Jeffrey V. Lazarus Prof. Shira Zelber Sagi, RACHAEL SOOD RN, MSN, APRN, NP-C, CDCES, Pinnacle Clinical Research